Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × CYP3A Phenotyping × Docetaxel × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 258 Carcinoma, Non-Small-Cell Lung 186 Prostatic Neoplasms 149 Lung Neoplasms 85 Stomach Neoplasms 62 Neoplasms 61 Head and Neck Neoplasms 51 Squamous Cell Carcinoma of Head and Neck 49 Esophageal Neoplasms 46 Neoplasm Metastasis 41 Ovarian Neoplasms 34 Pancreatic Neoplasms 25 Sarcoma 20 Urinary Bladder Neoplasms 19 Carcinoma, Ovarian Epithelial 17 Adenocarcinoma Of Esophagus 17 Breast Neoplasms, Male 16 Unspecified Adult Solid Tumor, Protocol Specific 15 Adenocarcinoma of Lung 15 Esophageal Squamous Cell Carcinoma 14 Carcinoma, Squamous Cell 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Fallopian Tube Neoplasms 12 Melanoma 10 Adenocarcinoma 10 Triple Negative Breast Neoplasms 9 Inflammatory Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Salivary Gland Neoplasms 8 Endometrial Neoplasms 8

Interventions

Docetaxel 1 CEF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01110291 2010-04-27

Docetaxel

University of Turku

CYP3A Phenotyping

Data powered by HemOnc (CC BY 4.0) Colophon ⚡